Voloridge Investment Management
ONC

Voloridge Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Voloridge Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,614
Closed -$479K – 1126
2026
Q1 		$479K Sell
1,614
-34,925
-96% -$11.3M ﹤0.01% 946
2025
Q4 		$11.1M Sell
36,539
-11,216
-23% -$3.67M 0.04% 555
2025
Q3 		$16.3M Buy
+47,755
New +$14.5M 0.05% 407
2025
Q2 		– Sell
-102,969
Closed -$28M – 1435
2025
Q1 		$28M Buy
+102,969
New +$24.1M 0.1% 267
2023
Q4 		– Sell
-10,291
Closed -$1.85M – 1540
2023
Q3 		$1.85M Sell
10,291
-13,159
-56% -$2.6M 0.01% 946
2023
Q2 		$4.18M Buy
23,450
+9,128
+64% +$2.1M 0.02% 739
2023
Q1 		$3.09M Buy
+14,322
New +$3.44M 0.02% 837
2022
Q4 		– Sell
-10,275
Closed -$1.39M – 1671
2022
Q3 		$1.39M Buy
+10,275
New +$1.76M 0.01% 1085
2021
Q3 		– Sell
-7,171
Closed -$2.46M – 1907
2021
Q2 		$2.46M Sell
7,171
-1,237
-15% -$410K 0.02% 919
2021
Q1 		$2.93M Sell
8,408
-18,797
-69% -$6.22M 0.02% 675
2020
Q4 		$7.03M Buy
+27,205
New +$7.49M 0.06% 370
2020
Q1 		– Sell
-40,541
Closed -$6.72M – 1455
2019
Q4 		$6.72M Buy
40,541
+36,812
+987% +$6.12M 0.13% 204
2019
Q3 		$457K Buy
3,729
+1,840
+97% +$244K 0.01% 828
2019
Q2 		$234K Buy
+1,889
New +$240K 0.01% 684
2018
Q3 		– Sell
-12,521
Closed -$1.93M – 497
2018
Q2 		$1.93M Buy
12,521
+8,121
+185% +$1.45M 0.05% 278
2018
Q1 		$739K Buy
+4,400
New +$596K 0.02% 388

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Voloridge Investment Management's ONC Position: Q2 2026 in Review

Voloridge Investment Management sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 1,614 shares — an estimated $479K sold.

Voloridge Investment Management first reported a position in ONC in Q1 2018 and held it in 16 quarters. The position peaked at $28M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Voloridge Investment Management reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 1,614 BeOne Medicines Ltd shares in Q2 2026, an estimated $479K.
  • Voloridge Investment Management first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 16 quarters.
  • Voloridge Investment Management's BeOne Medicines Ltd position peaked at $28M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.